Presentation is loading. Please wait.

Presentation is loading. Please wait.

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits  Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Published byAnne-Sophie Chrétien Modified over 5 years ago

Similar presentations

Presentation on theme: "No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits  Christian Olsson, MD, Agneta Siegbahn, MD, PhD,"— Presentation transcript:

1 No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits  Christian Olsson, MD, Agneta Siegbahn, MD, PhD, Eric Haldén, MD, PhD, Bo Nilsson, MD, PhD, Per Venge, MD, PhD, Stefan Thelin, MD, PhD  The Annals of Thoracic Surgery  Volume 69, Issue 3, Pages (March 2000) DOI: /S (99)

2 Fig 1 Median plasma levels of lactoferrin (LF) during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) doses of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass, Prot = after protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3 Fig 2 Median plasma levels of myeloperoxidase (MPO) during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) doses of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass; Prot = After protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4 Fig 3 Median plasma levels of Interleukin-6 (IL-6) during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) doses of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass; Prot = after protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

5 Fig 4 Median plasma levels of terminal [C5a-9] complement complex (TCC) during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) doses of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass; Prot = after protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

6 Fig 5 Median plasma levels of complement factor C3a during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) doses of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass; Prot = after protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

7 Fig 6 Median plasma levels of thrombin-antithrombin complex (TAT) during and after cardiopulmonary bypass with heparin-coated circuits and reduced (group R, filled triangles ▴) or standard (group S, open squares □) dose of systemic heparin. Error bars represent interquartile ranges. (Baseline = at anesthesia; CPB = on cardiopulmonary bypass; Prot = after protamine.) The Annals of Thoracic Surgery  , DOI: ( /S (99) )

Download ppt "No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits  Christian Olsson, MD, Agneta Siegbahn, MD, PhD,"

Similar presentations

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass  Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass  Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.
Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits  Piet G.M. Jansen, MD,

Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits  Piet G.M. Jansen, MD,
Heparin-coated cardiopulmonary bypass equipment. II

Heparin-coated cardiopulmonary bypass equipment. II
Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD,

Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD,
Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation  Knut Tore Lappegård, MD, Michael.

Effect of complement inhibition and heparin coating on artificial surface–induced leukocyte and platelet activation  Knut Tore Lappegård, MD, Michael.
Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface- Induced Eicosanoid Production  Knut Tore Lappegård, MD, Johan Riesenfeld,

Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface- Induced Eicosanoid Production  Knut Tore Lappegård, MD, Johan Riesenfeld,
Sally Bannan, Amanda Danby, Dahlia Cowan, Saeed Ashraf, Paul G Martin 

Sally Bannan, Amanda Danby, Dahlia Cowan, Saeed Ashraf, Paul G Martin 
Cerebral Oxygen Saturation Does Not Normalize Until After Stage 2 Single Ventricle Palliation  Kathleen N. Fenton, MD, Katherine Lessman, BS, Kimberly.

Cerebral Oxygen Saturation Does Not Normalize Until After Stage 2 Single Ventricle Palliation  Kathleen N. Fenton, MD, Katherine Lessman, BS, Kimberly.
Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass  Oddvar Moen, MD, Kolbjørn Høgåsen,

Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass  Oddvar Moen, MD, Kolbjørn Høgåsen,
A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,
Rewarming Rate During Cardiopulmonary Bypass Is Associated With Release of Glial Fibrillary Acidic Protein  Daijiro Hori, MD, Allen D. Everett, MD, Jennifer.

Rewarming Rate During Cardiopulmonary Bypass Is Associated With Release of Glial Fibrillary Acidic Protein  Daijiro Hori, MD, Allen D. Everett, MD, Jennifer.
Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study  Song Wan, MD, PhD, Jean-Louis.

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study  Song Wan, MD, PhD, Jean-Louis.
Randomized Comparison Between Normothermic and Hypothermic Cardiopulmonary Bypass in Pediatric Open-Heart Surgery  Massimo Caputo, MD, Simon Bays, Chris.

Randomized Comparison Between Normothermic and Hypothermic Cardiopulmonary Bypass in Pediatric Open-Heart Surgery  Massimo Caputo, MD, Simon Bays, Chris.
P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J
James L Zellner, MD, Scott B Kribbs, BS, B

James L Zellner, MD, Scott B Kribbs, BS, B
Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 
Assessment of heparin anticoagulation: comparison of two commercially available methods  Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Assessment of heparin anticoagulation: comparison of two commercially available methods  Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,
Is kidney function altered by the duration of cardiopulmonary bypass?

Is kidney function altered by the duration of cardiopulmonary bypass?
Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit  Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit  Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Similar presentations

Ads by Google